NHS England plans £79.2m framework for trastuzumab subcutaneous injection
Health service seeks suppliers for new cancer treatment delivery method through planned procurement.
Written with data automation, reviewed by the editor · Published
NHS England has announced a planned procurement for a national framework covering trastuzumab subcutaneous injection, with an estimated value of £79.2 million. The notice invites suppliers planning to introduce the molecule to contact the MPSC New Market Developments Team. The framework is expected to be procured through a competitive process.
Key facts
buyer
NHS England
value
£79.2 million estimated
supplier
Not yet appointed
published
3 July 2026
procedure or type
Planned procurement framework
NHS England has published a planned procurement notice for a National Framework for Trastuzumab Subcutaneous Injection, signalling an upcoming tender with an estimated value of £79.2 million.
The notice, published on 3 July 2026, invites suppliers planning to introduce the molecule detailed in the framework to make contact before the formal procurement exercise begins. The reference number for the offer is CM/TNS/26/5762.